{
  "timestamp": "2025-10-13T22:59:17.429732",
  "claims": {
    "9d82f476-dcc4-4892-a1e5-1c6a220fb76e": {
      "description": "CBD selectivity index 1.53 (corrected from 2.86 claim)",
      "confidence": 0.6,
      "evidence_sources": [
        "IRIS_S8_document",
        "CBD_v2_session"
      ],
      "iris_convergence": 0.85,
      "last_validated": null
    },
    "730bc50d-af88-4d8f-af02-571f68fbe49f": {
      "description": "Rhythm patterns 0.5-2.0 Hz indicate pulse dosing potential",
      "confidence": 0.4,
      "evidence_sources": [
        "IRIS_S4_patterns"
      ],
      "iris_convergence": 0.78,
      "last_validated": null
    },
    "0e3a1a46-619b-4a19-83ed-f3afa453c9cb": {
      "description": "Center stability 0.7-0.98 suggests therapeutic window",
      "confidence": 0.5,
      "evidence_sources": [
        "IRIS_S4_patterns"
      ],
      "iris_convergence": 0.82,
      "last_validated": null
    },
    "1af0c308-c8c9-43b8-9784-fe14a757909a": {
      "description": "Aperture range 0.3-0.9 correlates with dosing flexibility",
      "confidence": 0.3,
      "evidence_sources": [
        "IRIS_S4_patterns"
      ],
      "iris_convergence": 0.75,
      "last_validated": null
    },
    "202d140c-c2e9-48d7-8431-60efc19e6036": {
      "description": "VDAC1 direct binding validated with therapeutic KD range",
      "confidence": 0.45000000000000007,
      "evidence_sources": [
        "Literature_2024_VDAC1",
        "Multiple_binding_studies",
        "CBD-VDAC1 crystal structure reveals allosteric site (2025)",
        "Chloride channel CBD binding confirmed via cryo-EM (2025)"
      ],
      "iris_convergence": null,
      "last_validated": "2025-10-13T22:59:17.429317"
    },
    "a344ed1f-04c3-46ca-9288-9b396c224a75": {
      "description": "ROS-dependent selectivity mechanism confirmed",
      "confidence": 0.7,
      "evidence_sources": [
        "Literature_2024_ROS",
        "Oxidative_stress_studies"
      ],
      "iris_convergence": null,
      "last_validated": null
    },
    "12c7c803-41aa-44eb-88af-3b1a0d6f7e5c": {
      "description": "TRPV4 emerging as biomarker for CBD response",
      "confidence": 0.43333333333333335,
      "evidence_sources": [
        "Literature_2025_TRPV4",
        "Biomarker_studies",
        "TRPV4-MCU crosstalk mediates CBD selectivity (2025)"
      ],
      "iris_convergence": null,
      "last_validated": "2025-10-13T22:59:17.429300"
    },
    "29362a96-381a-4528-86bf-5a82db2bea50": {
      "description": "MCU-CBD interaction gap requires investigation",
      "confidence": 0.3,
      "evidence_sources": [
        "Literature_gap_analysis"
      ],
      "iris_convergence": null,
      "last_validated": null
    },
    "d04e779f-72e7-4300-84c8-d3c0fc48bc5b": {
      "description": "Chloride channel mechanisms remain unclear",
      "confidence": 0.2,
      "evidence_sources": [
        "Literature_review_2025"
      ],
      "iris_convergence": null,
      "last_validated": null
    },
    "da66f1f5-6974-4f51-899c-0f4cd5c5a61b": {
      "description": "Channel-first mechanism superior to receptor-first approach",
      "confidence": 0.7,
      "evidence_sources": [
        "Mechanism_comparison_2024",
        "IRIS_convergence"
      ],
      "iris_convergence": null,
      "last_validated": null
    }
  },
  "experiments": {
    "c7b550cb-ba12-4313-8471-ccadce1bdc71": {
      "type": "binding_assay",
      "priority_score": 0.9007153729071539,
      "estimated_duration": 14,
      "protocol": {
        "target": "VDAC1",
        "method": "SPR_analysis",
        "cbd_concentrations": [
          1,
          5,
          10,
          25,
          50,
          100
        ],
        "duration": "real_time_kinetics"
      },
      "success_criteria": {
        "kd_in_range": true,
        "specific_binding": "> 80%",
        "reproducibility": "> 0.9"
      }
    },
    "fb1a5ff0-a798-449c-bb8c-070144ca5469": {
      "type": "selectivity_index",
      "priority_score": 0.9310730593607307,
      "estimated_duration": 21,
      "protocol": {
        "cell_lines": [
          "U87MG",
          "normal_astrocytes",
          "HEK293"
        ],
        "cbd_concentrations": [
          1,
          5,
          10,
          25,
          50
        ],
        "timepoints": [
          24,
          48,
          72
        ],
        "readouts": [
          "viability",
          "apoptosis",
          "ROS_levels"
        ]
      },
      "success_criteria": {
        "selectivity_achieved": true,
        "ros_correlation": "> 0.7",
        "dose_response": "sigmoidal"
      }
    },
    "686dfe9c-e86f-4ac2-bb74-fc71d955a4c1": {
      "type": "biomarker_validation",
      "priority_score": 0.8014307458143075,
      "estimated_duration": 28,
      "protocol": {
        "target": "TRPV4",
        "assays": [
          "qPCR",
          "Western_blot",
          "flow_cytometry"
        ],
        "treatment_groups": [
          "vehicle",
          "cbd_10uM",
          "cbd_25uM"
        ],
        "timepoints": [
          6,
          12,
          24,
          48
        ]
      },
      "success_criteria": {
        "significant_change": "p < 0.05",
        "dose_response": true,
        "specificity": "> 0.8"
      }
    },
    "4ee4aed3-ae6a-4916-8e49-bca140b9e379": {
      "type": "dosing_optimization",
      "priority_score": 0.7517884322678844,
      "estimated_duration": 35,
      "protocol": {
        "pulse_frequencies": [
          0.5,
          1.0,
          1.5,
          2.0
        ],
        "continuous_vs_pulsed": true,
        "total_dose_matched": true,
        "duration": 72
      },
      "success_criteria": {
        "frequency_optimum": true,
        "pulse_superiority": true,
        "safety_margin": "> 2-fold"
      }
    }
  }
}